These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 7407778)

  • 1. Proceedings of the Symposium on Designs for Clinical Cancer Reseach. Discussion I: Basic design considerations.
    Cancer Treat Rep; 1980; 64(2-3):411-7. PubMed ID: 7407778
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings of the Symposium on Designs for Clinical Cancer Research. Perspective of the clinician.
    Hoogstraten B
    Cancer Treat Rep; 1980; 64(2-3):537-8. PubMed ID: 7407796
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings of the Symposium on Designs for Clinical Cancer Research. Discussion III: Designs to optimize combined-modality therapy and selection and verification of prognostic factors.
    Cancer Treat Rep; 1980; 64(2-3):497-8. PubMed ID: 7407789
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings of the Symposium on Designs for Clinical Cancer Research. Discussion II: Critical definitions and criteria for evaluation.
    Cancer Treat Rep; 1980; 64(2-3):469-71. PubMed ID: 7407786
    [No Abstract]   [Full Text] [Related]  

  • 5. Designing for cancer clinical trials: selection of prognostic factors.
    Brown BW
    Cancer Treat Rep; 1980; 64(2-3):499-502. PubMed ID: 7407790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings of the Symposium on Designs for Clinical Cancer Research. Summary views: A statistician's perspective.
    Cox DR
    Cancer Treat Rep; 1980; 64(2-3):533-5. PubMed ID: 7407795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial designs for predictive marker validation in cancer treatment trials.
    Sargent DJ; Conley BA; Allegra C; Collette L
    J Clin Oncol; 2005 Mar; 23(9):2020-7. PubMed ID: 15774793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized clinical trials and research strategy.
    Simon R
    Cancer Treat Rep; 1982 May; 66(5):1083-7. PubMed ID: 7083212
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of the alternative methods of calculating survival curves arising from clinical trials.
    Sylvester RJ; Machin D; Staquet MJ
    Biomedicine; 1978 Sep; 28 Spec No():49-53. PubMed ID: 363196
    [No Abstract]   [Full Text] [Related]  

  • 10. Subject-own-control designs from a statistical perspective.
    Fleiss JL
    Psychopharmacol Bull; 1979 Jul; 15(3):42-4. PubMed ID: 493461
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized phase II designs in cancer clinical trials: current status and future directions.
    Lee JJ; Feng L
    J Clin Oncol; 2005 Jul; 23(19):4450-7. PubMed ID: 15994154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative clinical trials with historical controls: a statistician's view.
    Gehan EA
    Biomedicine; 1978 Sep; 28 Spec No():13-9. PubMed ID: 363189
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biostatistics in cancer clinical trials].
    Ohashi Y
    Gan To Kagaku Ryoho; 1998 Jan; 25(2):241-52. PubMed ID: 9480646
    [No Abstract]   [Full Text] [Related]  

  • 14. Human models for cancer active immunotherapy.
    Mathé G
    Biomedicine; 1977 Feb; 26(1):1-5. PubMed ID: 324528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and analysis of prostate cancer trials.
    Sylvester R
    Acta Urol Belg; 1994 Apr; 62(1):23-9. PubMed ID: 8197926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation in flexible two stage designs.
    Brannath W; König F; Bauer P
    Stat Med; 2006 Oct; 25(19):3366-81. PubMed ID: 16220489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performing serial testing of treatment effects.
    Fleming TR; Green SJ; Harrington DP
    Experientia Suppl; 1982; 41():469-84. PubMed ID: 6958531
    [No Abstract]   [Full Text] [Related]  

  • 18. The advantages and disadvantages of adaptive designs for clinical trials.
    Bauer P; Brannath W
    Drug Discov Today; 2004 Apr; 9(8):351-7. PubMed ID: 15081962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of toxicity: statistical considerations.
    Herson J
    Cancer Treat Rep; 1980; 64(2-3):463-8. PubMed ID: 7407785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials: what you and your patients need to know.
    Yoder LH
    Medsurg Nurs; 2005 Oct; 14(5):351-3; quiz 354. PubMed ID: 16318119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.